Brief: Check-Cap Announces FDA Approval Of Amended IDE Application For Pivotal Study Of C-Scan
07/02/2022 13:44
Feb 7 (Reuters) - Check Cap Ltd CHEK.O :
* CHECK-CAP ANNOUNCES FDA APPROVAL OF AMENDED IDE
APPLICATION FOR
PIVOTAL STUDY OF C-SCAN
* CHECK CAP LTD - ANTICIPATES INITIATION OF FIRST PART OF
STUDY IN
MARCH-APRIL 2022 TIMEFRAME
* CHECK CAP LTD - COMPANY ANTICIPATES INITIATION OF FIRST
PART OF
PIVOTAL STUDY IN MARCH-APRIL 2022 TIMEFRAME
Source text for Eikon: ID:nPn7HMSGHa
Further company coverage: CHEK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mbody Ai
See all newsBrief: Check-Cap Ltd. Announces Pricing Of $10 Million Public Offering Of Ordinary Shares
Brief: Check-Cap Announces $12.50 Mln Firm Commitment Public Offering Of Ordinary Shares
Brief: Check-Cap (Mbai) Advances Merger With Mbody Ai Reverse Share Split Effective
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM